Permeability of the Blood-Brain Barrier to a Rhenacarborane
Authors:
- Paul A. JellissPJPaul A. Jelliss
- Naoko NonakaNNNaoko Nonaka
- Xiaoming ShiXSXiaoming Shi
- William A. BanksWBWilliam A. Banks
- 1 May 2009
- journal article
- Published by Elsevier in The Journal of Pharmacology and Experimental Therapeutics
- Vol. 329 (2) , 608-614
Abstract
The treatment of brain malignancies with boron neutron capture therapy depends on their ability to cross the blood-brain barrier (BBB). An especially promising class of boron-containing compounds is the rhenacarboranes that, if able to cross the BBB, could act as delivery vehicles as well as a source of boron. Here, we examined the ability of the 3-NO-3,3-κ2-(2,2′-N2C10H6(Me){(CH2)7131I}-4,4′)-closo-3,1,2-ReC2B9H11 (rhenacarborane) labeled with iodine-131 to be taken up into the bloodstream after subcutaneous administration and to cross the BBB. The 131I-rhenacarborane was quickly absorbed from the injection site and reached a steady state in arterial serum of 2.59%/ml of the administered dose. Between 73 and 95% of the radioactivity in serum 6 h after administration represented intact 131I-rhenacarborane. Its octanol/buffer partition coefficient was 1.74, showing it to be lipophilic. Tissue/serum ratios for brain, lung, and liver showed classic patterns for a lipid-soluble substance with high levels immediately achieved and rapid redistribution. For brain, a steady state of approximately 0.107% of the administered dose/gram-brain was rapidly reached, and 71% of the radioactivity in brain 6 h after subcutaneous administration represented intact 131I-rhenacarborane. Steady-state values were 1.53 and 0.89% of the injected dose per gram for lung and liver, respectively. 131I-Rhenacarborane was quickly effluxed from brain by a nonsaturable system after its injection into the lateral ventricle of the brain. In conclusion, these results show that a rhenacarborane was enzymatically resistant and able to cross the BBB by transmembrane diffusion and accumulate in brain in substantial amounts. This supports their use as therapeutic agents for targeting the central nervous system.Keywords
This publication has 34 references indexed in Scilit:
- Microwave-Assisted Synthesis of Tricarbonyl Rhenacarboranes: Steric and Electronic Effects on the 1,2 → 1,7 Carborane Cage IsomerizationInorganic Chemistry, 2007
- Microwave-Assisted Synthesis of 3,1,2- and 2,1,8-Re(I) and 99mTc(I)−Metallocarborane ComplexesInorganic Chemistry, 2006
- Synthesis of Ortho- and Meta-Re(I)-Metallocarboranes in WaterInorganic Chemistry, 2005
- Preparation of Re(I)− and 99mTc(I)−Metallocarboranes in Water under Weakly Basic Reaction ConditionsInorganic Chemistry, 2004
- The Impact of Efflux Transporters in the Brain on the Development of Drugs for CNS DisordersClinical Pharmacokinetics, 2002
- Changing the chemokine gradient: CINC1 crosses the blood–brain barrierJournal of Neuroimmunology, 2001
- Rhenacarborane complexes with nitrosyl and alkylidene ligands. Structures of the complexes [Re{C(OMe)C6H4Me-4}(NO)(CO)(η5-7,8-C2B9H11)] and [Re(NO)(CNBut){η5,σ-7-CN(H)But-7,8-C2B9H10}]Chemical Communications, 1999
- Synthesis and Crystal Structure of the Novel Dianion [Re(CO)3(η5-7-CB10H11)]2-. Reactions with Platina- and Palladaphosphine ChloridesOrganometallics, 1998
- Inability of Dimethyl Sulfoxide and 5-Fluorouracil to Open the Blood-Brain BarrierNeurosurgery, 1983
- Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeabilityJournal of Medicinal Chemistry, 1980